NCT04947085View on ClinicalTrials.gov

Comparison of Nebulized Ketamine to Intravenous Sub-Dissociative Dose Ketamine for Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 4, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

December 31, 2023

Conditions
Pain
Interventions
DRUG

Ketamine via Intravenous

Ketamine administration in sub-dissociative doses

DRUG

Ketamine via BAN

Ketamine administered via Breath-Actuated Nebulizer (BAN)

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

All Listed Sponsors
lead

Antonios Likourezos

OTHER

NCT04947085 - Comparison of Nebulized Ketamine to Intravenous Sub-Dissociative Dose Ketamine for Pain | Biotech Hunter | Biotech Hunter